Xocova COVID Prevention Pill

What Is Xocova Used For After COVID Exposure?

Xocova is the brand name for ensitrelvir, a SARS-CoV-2 main protease inhibitor. The FDA's 2026 novel drug approvals list identifies Xocova as approved for post-exposure prophylaxis of COVID-19 after contact with an infected person, making it a prevention-focused antiviral rather than a U.S.-approved treatment for active COVID-19 illness.

The approval matters because post-exposure prophylaxis fills a practical gap between vaccination and treatment. Vaccines remain the foundation of prevention, but a short oral course after a high-risk exposure may be useful for household contacts, people living with medically vulnerable relatives, and settings where rapid action after exposure could reduce downstream illness.

How Strong Is The Evidence Behind Ensitrelvir?

SCORPIO-PEP enrolled household contacts aged 12 years and older who tested negative for SARS-CoV-2 and had no symptoms at enrollment. Participants started ensitrelvir or placebo within 72 hours of symptom onset in the infected household member, a timing window that fits the biology of antiviral prevention because viral replication begins early after exposure.

According to Shionogi's report of the trial and the NEJM publication, the primary analysis included 2,041 household contacts and showed a 67% relative reduction in symptomatic COVID-19 through day 10 compared with placebo. Adverse event rates were similar between groups in the trial, but real-world prescribing still requires careful review of contraindications, pregnancy status, breastfeeding, and drug-drug interactions.

Who Should Discuss COVID Post-Exposure Prophylaxis With A Clinician?

Because Xocova must be started soon after exposure, the clinical decision is time-sensitive. A clinician or pharmacist will need to confirm the exposure history, symptom status, age eligibility, current medicines, and whether testing suggests active infection rather than prevention after exposure.

This approval does not replace vaccination, ventilation, masking in high-risk situations, or staying home when ill. It adds another tool for selected exposed patients, particularly when a close household contact has confirmed COVID-19 and preventing symptomatic infection could protect both the exposed person and others around them.